Bicycle Therapeutics (BCYC) Tax Provisions (2018 - 2026)
Bicycle Therapeutics' (BCYC) quarterly Tax Provisions came in at $100000.0 in Q2 2026, up 143.29% YoY from $41103.2 in Q2 2025, and down 50.0% on a QoQ basis from $200000.0 in Q1 2026.
Analysis
Bicycle Therapeutics (BCYC) Tax Provisions (2018 - 2026) Analysis & Trends
Bicycle Therapeutics (BCYC) has 9 years of Tax Provisions data on file, last reported at $100000.0 in Q2 2026.
- Quarterly Tax Provisions rose 143.29% year-over-year to $100000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$53.1 million (down 802.94% YoY) and the FY2025 annual result came in at -$54.7 million, down 1039.62% from the prior year.
- Tax Provisions slipped to $100000.0 in Q2 2026, from $200000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $4.6 million in Q4 2022 to a low of -$53.6 million in Q4 2025.
- A 5-year average of -$3.2 million and a median of -$409500.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions jumped 1066.39% — and 2025, when it sank 4771.73%.
- Tracing BCYC's Tax Provisions over 5 years: stood at $4.6 million in 2022, then slumped by 165.54% to -$3.0 million in 2023, then surged by 63.16% to -$1.1 million in 2024, then slumped by 4771.73% to -$53.6 million in 2025, then jumped by 100.19% to $100000.0 in 2026.
- The last three Tax Provisions figures came in at $100000.0 (Q2 2026), $200000.0 (Q1 2026), and -$53.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Bicycle Therapeutics | 297.72 Mn | 297.72 Mn | - | 100,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | -53.59 Mn |
| Sep 30, 2025 | 205,000.00 |
| Jun 30, 2025 | -231,000.00 |
| Mar 31, 2025 | -1.10 Mn |
| Dec 31, 2024 | -1.10 Mn |
| Sep 30, 2024 | -3.45 Mn |
| Jun 30, 2024 | 115,000.00 |
| Mar 31, 2024 | -400,000.00 |
| Dec 31, 2023 | -2.99 Mn |
| Sep 30, 2023 | 2.30 Mn |
| Jun 30, 2023 | -517,000.00 |
| Mar 31, 2023 | -618,000.00 |
| Dec 31, 2022 | 4.56 Mn |
| Sep 30, 2022 | -238,000.00 |
| Jun 30, 2022 | -447,000.00 |
| Mar 31, 2022 | -419,000.00 |
| Dec 31, 2021 | -785,000.00 |
| Sep 30, 2021 | -415,000.00 |